Stock PSYB.H PSYBIO THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart PsyBio Therapeutics Corp.

Equities

PSYB.H

CA6936971044

Delayed Toronto S.E.
Other stock markets
 09:54:13 29/03/2024 am IST 		5-day change 1st Jan Change
0.01 CAD -.--% Intraday chart for PsyBio Therapeutics Corp. -.--% -.--%
2021 PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs CI
2021 PsyBio Therapeutics : Files Novel Psychedelic Compositions and Methods of Treatment Patent With USPTO MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PSYBIO THERAPEUTICS CORP. Stock PsyBio Therapeutics Corp.
 965K - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.22B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.02B -
  1. Stock Market
  2. Equities
  3. PSYB.H Stock
  4. Charts PsyBio Therapeutics Corp.
  5. Sector Chart